The Biology of Prostate Cancer Metastasis and What PSMA Imaging Is Teaching Us: Presentation and Discussion – Kenneth J. Pienta

A Step Towards Personalized Medicine: PSMA PET Imaging in Prostate Cancer. The Biology of Prostate Cancer Metastasis and What PSMA Imaging is Teaching Us Independent Medical Education Initiative Supported by Progenics Pharmaceuticals, Inc. a subsidiary of Lantheus Holdings, Inc. Biographies: Presenter: Kenneth J. Pienta, MD, is the Donald S. Coffey Professor at the Brady Urological Institute at…

Read the full article here

Source: UroToday

Categories: Latest Headlines, Urology

Tags: ProstateCancer, PSMAImaging

Tweets with this article

UroToday.com

The biology of #ProstateCancer metastasis and what #PSMAImaging is teaching us. Presentation by @pienta_brady @brady_urology. Discussion with @CaPsurvivorship, @PhillipKooMD, and Neal Shore, MD, FACS @AtlanticUrology on UroToday > https://t.co/INTb1OWwJm @Progenics https://t.co/UwEjrnhqeQ

Does Research from Clinical Trials in Metastatic Hormone-sensitive Prostate Cancer Treatment Translate into Access to Treatments for Patients in the “Real World”? A Systematic Review – Beyond the Abstract

prostate cancer, metastatic hormone sensitive prostate cancer (mHSPC), Metastatic Hormone-sensitive Prostate Cancer Treatment, Docetaxel, Novel Hormonal Therapy (NHT), enzalutamide, apalutamide, abiraterone, androgen deprivation therapy (ADT).

UroToday.com April 17, 2024

Bone Health Management for Advanced Prostate Cancer – Fred Saad

Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC Bone Health Management for Advanced Prostate Cancer – Fred Saad Part…

UroToday.com April 17, 2024

Triplet Delays Further Therapy Versus Doublet in Metastatic HSPC – Neal Shore

Neal Shore discusses the ARASENS trial’s post hoc analysis, emphasizing the benefits of triplet therapy in advanced hormone-sensitive prostate cancer. This study adds to the…

UroToday.com April 17, 2024

Testicular Cancer Survivors Find Community and Healing Through Foundation and Patient Summit – Connor O’Leary & Charles Freeman McCluskey

Zach Klaassen hosts a discussion with Connor O’Leary and Freeman McClusky, both testicular cancer survivors. They delve into the history and mission of Testicular Cancer…

UroToday.com April 17, 2024

How Mental Health Disorders Impact Treatment Decisions in Localized Prostate Cancer – Yaw Nyame & Joshua Cabral

Ruchika Talwar hosts Joshua Cabral and Yaw Nyame to explore the impact of mental health disorders on prostate cancer care. Their study, “Inequities in Definitive…

UroToday.com April 17, 2024

AUA Guidelines Provide Roadmap for Assessing Disease Burden and Personalizing Systemic Therapies in Metastatic Hormone Sensitive Prostate Cancer, Journal Club – Rashid Sayyid & Zachary Klaassen

Rashid Sayyid and Zach Klaassen discuss the 2023 amended AUA guidelines for advanced prostate cancer, focusing on metastatic hormone-sensitive prostate cancer (mHSPC). They emphasize the…

UroToday.com April 17, 2024

Cancer-Specific Survival of Patients with Non-Muscle-Invasive Bladder Cancer: A Population-Based Analysis – Beyond the Abstract

non-muscle invasive bladder cancer (NMIBC), transurethral resection of the bladder tumor (TURBT), Tumor T stage, cancer-specific survival (CSS) in patients with non-muscle invasive bladder cancer…

UroToday.com April 17, 2024

Related Articles